Nuclear factor-κB as a molecular target for migraine therapy

Annals of Neurology

Volumn 51, Issue 4, 2002, Pages 507-516

  Reuter, Uwe ^a   Chiarugi, Alberto ^a   Bolay, Hayrunnisa ^a   Moskowitz, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; DNA BINDING PROTEIN; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; N ACETYL S NITROSOPENICILLAMINE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NITRIC OXIDE DONOR; NONSTEROID ANTIINFLAMMATORY AGENT; NOS2 PROTEIN, RAT; PARTHENOLIDE; SESQUITERPENE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DURA MATER; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; MACROPHAGE ACTIVATION; MAST CELL DEGRANULATION; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; ENZYMOLOGY; MACROPHAGE; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DNA-BINDING PROTEINS; DURA MATER; I-KAPPA B PROTEINS; MACROPHAGES; MALE; MIGRAINE DISORDERS; NF-KAPPA B; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITROGLYCERIN; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSO-N-ACETYLPENICILLAMINE; SESQUITERPENES; VASODILATOR AGENTS;

EID: 0036009156     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10159     Document Type: Article

References (50)

1. Neurobiology of nitric oxide
2. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles
3. The 5-hydroxytryptamine-nitric oxide connection: The key link in the initiation of migraine?
4. 5-HT2 receptor antagonists and migraine therapy
5. Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain
6. Headaches in explosive magazine workers
7. Nitric oxide synthase inhibition in migraine
8. Delayed inflammation in rat meninges: Implications for migraine pathophysiology
9. Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms
10. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase
11. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha
12. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B
13. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene
14. Cytokine induction of NO synthase II in human DLD-1 cells: Roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways
15. Oxidative stress increases hepatocyte iNOS gene transcription and promoter activity
16. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production
17. Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit
18. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
19. Herbal medicines in migraine prevention: Randomised double-blind, placebo-controlled crossover trial of a feverfew preparation
20. Feverfew as a prohylactic treatment for migraine: A double blind placebo controlled study
21. The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IκB kinase
22. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones
23. Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats
24. Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins
25. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of IκB-α and IκB-β
26. The anti-inflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex
27. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
28. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide
29. Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells
30. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
31. Involvement of NF-kappaB in silica-induced cyclooxygenase II gene expression in rat alveolar macrophages
32. Exogenous nitric oxide regulates IFN-gamma plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages
33. Co-stimulatory effect of nitric oxide on endothelial NF-κB implies a physiological self-amplifying mechanism
34. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide
35. Feedback inhibition of nitric oxide synthase activity by nitric oxide
36. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages
37. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B
38. Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells
39. Activity of Parthenolide at 5HT2A receptors
40. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes
41. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB
42. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain
43. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells
44. A. Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat
45. Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat
46. The efficacy and safety of feverfew (Tanacetum parthenium L.): An update of a systematic review
47. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study
48. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study
49. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
50. Effect of the chloroform extract of Tanacetum vulgare and one of its active principles, parthenolide, on experimental gastric ulcer in rats